Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZFP936 Inhibitors

The conceptual category of ZFP936 Inhibitors encompasses a range of compounds that, through their action on various signaling molecules and pathways, have the potential to indirectly modulate the activity or expression of ZFP936. Given ZFP936's presumed role as a zinc finger protein involved in transcriptional regulation, the selected inhibitors target mechanisms such as DNA methylation, histone acetylation, and chromatin remodeling. These processes are crucial for the regulation of gene expression and are pathways through which ZFP936 is likely to exert its biological effects.

This approach to identifying potential inhibitors underscores the complexity of transcriptional regulation and the interconnected nature of cellular signaling networks. By targeting key regulatory processes that influence gene expression, such as chromatin accessibility and the activity of transcription factors, these inhibitors offer insights into the biological functions of ZFP936 and its role in cellular processes. Through such exploration, the selected compounds not only facilitate a deeper understanding of ZFP936's involvement in gene expression but also underscore the broader principles of cellular regulation and signal transduction. This methodology exemplifies the potential of targeted chemical intervention to modulate the function of specific proteins indirectly, providing a foundation for further research into the mechanisms of transcriptional regulation and the role of zinc finger proteins like ZFP936 in these processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

DNMT inhibitor, potentially altering DNA methylation affecting ZFP936-regulated gene expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

HDAC inhibitor, could modify chromatin structure, potentially influencing ZFP936's role in transcription.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

Selective HDAC inhibitor, potentially affects chromatin accessibility and ZFP936 activity.

Panobinostat

404950-80-7sc-208148
10 mg
$196.00
9
(1)

Broad-spectrum HDAC inhibitor, might influence ZFP936's role in transcriptional regulation.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

DNA methyltransferase inhibitor, could affect methylation patterns of genes regulated by ZFP936.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

HDAC inhibitor, potentially affecting chromatin state and gene expression regulated by ZFP936.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

BET bromodomain inhibitor, could disrupt protein-protein interactions affecting ZFP936 function.

I-BET 151 Hydrochloride

1300031-49-5 (non HCl Salt)sc-391115
10 mg
$450.00
2
(0)

BET bromodomain inhibitor, might influence ZFP936-mediated gene regulation.

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
$90.00
$238.00
$300.00
(0)

EZH2 methyltransferase inhibitor, potentially affecting histone methylation and ZFP936 regulatory functions.

LY3214996

1951483-29-6sc-507299
5 mg
$260.00
(0)

ERK1/2 inhibitor, potentially impacts signaling pathways that ZFP936 may be involved in.